Next Quarterly Earnings
Monday, March 29, 2027
Expected
Veradermics is a US clinical-stage biopharmaceutical company developing prescription therapies for dermatological conditions. Its pipeline focuses on treatments for androgenetic hair loss as well as other skin disorders such as warts.
Veradermics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.58 USD.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.